CD27 Antikörper (FITC)

Produktnummer ABIN476506

Dieses Maus Monoklonal-Antikörper erkennt spezifisch CD27 in FACS. Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für CD27 Antikörper (FITC) (ABIN476506)

Target: CD27 (CD27 Molecule (CD27))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CD27 Antikörper ist konjugiert mit FITC

Applikation: Flow Cytometry (FACS)

Klon: O323

Produktdetails anti-CD27 Antikörper (FITC)

Aufreinigung: Affinity purified

Immunogen: Human CD27

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise: Approved: Flo

Usage: The O323 antibody has been pre-titrated and tested by flow cytometric analysis of human peripheral blood leukocytes. This can be used at 20 μL (1 μg)/per test. A test is defined as the amount (ug)/test of antibody that will stain a cell sample in a final volume of 100 μL. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: PBS,  pH 7.2, 150 mM sodium chloride, 0.09 % sodium azide, 0.2 % BSA

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Do not freeze. Product is photosensitive and should be protected from light.

Lagerung: 4 °C

Informationen zur Lagerung: Store at 4°C. Do not freeze. Protect from light.

Details zu CD27

Target: CD27 (CD27 Molecule (CD27))

Andere Bezeichnung: CD27

Hintergrund: Name/Gene ID: CD27
Family: TNF Receptor

Synonyms: CD27, CD27 antigen, CD27 Molecule, S152, T14, T-cell activation antigen CD27, CD27L receptor, T cell activation antigen S152, TNFRSF7, Tp55

Gen-ID: 939

UniProt: P26842

Pathways: Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints